G61.0
Guillain-Barre syndrome
Clinical Classification Guidelines
Inclusion Terms
- Acute (post-)infective polyneuritis
- Miller Fisher Syndrome
Medical Intelligence & Overview
Guillain-Barré syndrome (GBS) is a rare neurological disorder in which the body's immune system mistakenly attacks the peripheral nerves, which are responsible for transmitting signals between the brain, spinal cord, and the rest of the body. This condition often develops rapidly over days or weeks and can lead to muscle weakness, numbness, and even paralysis. GBS is considered an emergency medical condition requiring prompt diagnosis and treatment to improve outcomes and reduce the risk of complications. It can sometimes follow an infection, trauma, or surgery, and the exact cause remains unknown in many cases.
Causes & Symptoms
Clinical Causes: Previous infections, especially gastrointestinal or respiratory infections caused by bacteria or viruses Certain vaccinations, though rare Surgical procedures or trauma Underlying immune system disorders In some cases, no specific trigger can be identified
Key Symptoms: Rapidly progressing muscle weakness, starting in the legs and arms Numbness or tingling sensations in the limbs Difficulty with eye movements, facial expressions, or swallowing Loss of reflexes such as knee or ankle reflexes Severe cases may experience paralysis affecting breathing muscles Pain, often described as aching or cramping, especially in the muscles Autonomic dysfunction, leading to abnormal heart rate or blood pressure fluctuations
Diagnostic & Treatment
Diagnosis Path: Diagnosing Guillain-Barré syndrome involves a combination of clinical examination and specialized tests. Healthcare providers assess symptoms and perform neurological examinations to evaluate muscle strength, reflexes, and sensory responses. Confirmatory tests include lumbar puncture to analyze cerebrospinal fluid, which often shows elevated protein levels with normal cell count (called albuminocytological dissociation). Nerve conduction studies and electromyography (EMG) help to detect nerve damage and assess the extent of the progression. Early diagnosis is crucial for initiating appropriate treatment and improving recovery chances.
Treatment Protocols: Management of Guillain-Barré syndrome typically involves hospitalization and supportive care. Common treatments include:
Clinical Advice & FAQs
Billing Guidance
Is G61.0 a billable ICD-10 code?
Yes, G61.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G61.0?
Clinical documentation must specify the nature of Guillain-Barre syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference